tradingkey.logo
tradingkey.logo
Search

Alamar Biosciences Ord Shs

ALMR
Add to Watchlist
23.840USD
-2.110-8.13%
Close 07/20, 16:00ETQuotes delayed by 15 min
1.59BMarket Cap
--P/E TTM
You can check out the annual or quarterly balance sheets of Alamar Biosciences Ord Shs here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
Total equity
Cash, cash equivalents and short-term investments
--64.59M
- Cash and cash equivalents
--64.59M
Receivables
--19.52M
-Accounts and notes receivable
--19.52M
Inventory
--39.93M
Prepaid expenses
--17.43M
Total current assets
--141.47M
Non-current assets
Net Fixed Assets
--37.98M
Other non-current assets
--7.00M
Total non-current assets
--44.98M
Total assets
--186.45M
Liabilities
Current liabilities
-Other payables
--8.54M
Accrued expenses
--6.17M
Deferred liabilities
--2.11M
Other current liabilities
--10.64M
Total current liabilities
--24.05M
Non-current liabilities
Long-term debt and lease liabilities
--103.95M
-Long-term debt
--74.97M
-Long-term lease liabilities
--28.98M
Other non-current liabilities
--1.53M
Total non-current liabilities
--105.48M
Total liabilities
--129.53M
Shareholders' equity
Common equity
--12.11M
Retained earnings
---190.10M
Capital reserves
--12.11M
Gains losses not affecting retained earnings
---80.00K
Total equity
--56.92M
Currency unit
USD
Audit opinions
--

FAQs

What is the balance sheet?

It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.
tradingkey.logo
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.